These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23808268)

  • 1. [Cell therapy of critical lower limb ischemia (problems and prospects)].
    Lebedev SV; Karasev AV; Kungurtsev VV; Lokhonina AV; Kleĭmenova EB
    Vestn Ross Akad Med Nauk; 2013; (3):33-44. PubMed ID: 23808268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies.
    Qadura M; Terenzi DC; Verma S; Al-Omran M; Hess DA
    Stem Cells; 2018 Feb; 36(2):161-171. PubMed ID: 29226477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical limb ischemia: cell and molecular therapies for limb salvage.
    Davies MG
    Methodist Debakey Cardiovasc J; 2012; 8(4):20-7. PubMed ID: 23342184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials.
    Lakshmanan R; Ukani G; Rishi MT; Maulik N
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1125-1140. PubMed ID: 28407473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic angiogenesis of critical lower limb ischemia. Review of the literature and prospects of research on stem cells].
    Di Stefano R; Limbruno U; Barone D; Balbarini A
    Ital Heart J Suppl; 2004 Jan; 5(1):1-13. PubMed ID: 15253139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current state of stem cell therapy for peripheral artery disease.
    Gupta NK; Armstrong EJ; Parikh SA
    Curr Cardiol Rep; 2014 Feb; 16(2):447. PubMed ID: 24414120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell therapy in critical limb ischemia: current developments and future progress.
    Mamidi MK; Pal R; Dey S; Bin Abdullah BJ; Zakaria Z; Rao MS; Das AK
    Cytotherapy; 2012 Sep; 14(8):902-16. PubMed ID: 22731756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic transplantation of programmable cells of monocytic origin (PCMO) improves angiogenesis and tissue recovery in critical limb ischemia (CLI): a translational approach.
    Berndt R; Hummitzsch L; Heß K; Albrecht M; Zitta K; Rusch R; Sarras B; Bayer A; Cremer J; Faendrich F; Groß J
    Stem Cell Res Ther; 2018 Apr; 9(1):117. PubMed ID: 29703251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial progenitor cells for vasculogenesis.
    Murasawa S; Asahara T
    Physiology (Bethesda); 2005 Feb; 20():36-42. PubMed ID: 15653838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell therapy in critical limb ischemia: A comprehensive analysis of two cell therapy products.
    Tournois C; Pignon B; Sevestre MA; Al-Rifai R; Creuza V; Poitevin G; François C; Nguyen P
    Cytotherapy; 2017 Feb; 19(2):299-310. PubMed ID: 27914820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic angiogenesis in patients with severe limb ischemia by transplantation of a combination stem cell product.
    Lasala GP; Silva JA; Minguell JJ
    J Thorac Cardiovasc Surg; 2012 Aug; 144(2):377-82. PubMed ID: 22079876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of critical limb ischemia and diabetic foot disease by the use of autologous stem cells].
    Dubský M; Jirkovská A; Bém R; Pagácová L; Fejfarová V; Varga M; Skibová J; Langkramer S; Syková E
    Vnitr Lek; 2011 May; 57(5):451-5. PubMed ID: 21695925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell use in critical limb ischemia.
    Kolvenbach R; Kreissig C; Ludwig E; Cagiannos C
    J Cardiovasc Surg (Torino); 2007 Feb; 48(1):39-44. PubMed ID: 17308520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical limb ischemia.
    Elsayed S; Clavijo LC
    Cardiol Clin; 2015 Feb; 33(1):37-47. PubMed ID: 25439329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia.
    Ruiz-Salmeron R; de la Cuesta-Diaz A; Constantino-Bermejo M; Pérez-Camacho I; Marcos-Sánchez F; Hmadcha A; Soria B
    Cell Transplant; 2011; 20(10):1629-39. PubMed ID: 22289660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progenitor cell therapy in patients with critical limb ischemia without surgical options.
    Sprengers RW; Lips DJ; Moll FL; Verhaar MC
    Ann Surg; 2008 Mar; 247(3):411-20. PubMed ID: 18376183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal cord stimulation in critical limb ischemia of the lower extremities: our experience.
    Petrakis IE; Sciacca V
    J Neurosurg Sci; 1999 Dec; 43(4):285-93. PubMed ID: 10864391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic angiogenesis for peripheral artery disease: stem cell therapy.
    Lachmann N; Nikol S
    Vasa; 2007 Nov; 36(4):241-51. PubMed ID: 18357916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.
    Kawamoto A; Katayama M; Handa N; Kinoshita M; Takano H; Horii M; Sadamoto K; Yokoyama A; Yamanaka T; Onodera R; Kuroda A; Baba R; Kaneko Y; Tsukie T; Kurimoto Y; Okada Y; Kihara Y; Morioka S; Fukushima M; Asahara T
    Stem Cells; 2009 Nov; 27(11):2857-64. PubMed ID: 19711453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel potential therapy for vascular diseases: blood-derived stem/progenitor cells specifically activated by dendritic cells.
    Porat Y; Assa-Kunik E; Belkin M; Krakovsky M; Lamensdorf I; Duvdevani R; Sivak G; Niven MJ; Bulvik S
    Diabetes Metab Res Rev; 2014 Oct; 30(7):623-34. PubMed ID: 24638886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.